Pharming (PHAR) - Bozor kapitallashuvi
Pharming Group N.V. (PHAR) kam uchraydigan immun patologiyalarini davolashga ixtisoslashgan bo'lib, genetik jihatdan modifikatsiyalangan quyon sutidan innovatsion molekulalarni ajratib olishdan foydalanadi, bu esa Ruconest mahsulotini yuqori marjali mahsulotga aylantiradi. Hozirda 0.95 darajasida bo'lgan ushbu grafikdagi narx harakati ushbu muvaffaqiyatni ishlab chiqarish va sinovlarni to'liq tashqi hamkorlarga topshirish modeliga bog'laydi. Shu bilan birga, biznes uzoq muddatli kelishuvlar va raqamli logistika orqali CMO zavodlari bilan bog'liq qaramlik risklarini minimallashtiradi.
Pharming Corp (PHAR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Pharming Group N.V.|PHAR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Pharming Group N.V.|PHAR - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Pharming Corp|PHAR - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Pharming Group|Tezkor likvidlik koeffitsiyenti pharming.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PHAR - Sof foyda|Kelajakdagi foyda Pharming Group N.V.|PHAR - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Pharming|PHAR - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Pharming Corp|PHAR - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Pharming Group|PHAR - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi pharming.com|PHAR - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Pharming Group N.V.
Kompaniyaning fundamental tahlili:PHAR (Pharming Group)
Bozor kapitalizatsiyasi joriy aktivlarga bo'lgan talabni umumlashtirib, barcha chiqarilgan aksiyalarning umumiy qiymatini bozor kutuvlari prizmasi orqali aks ettiradi. Pharming Group N.V. (PHAR) aksiyalarining bozor qiymati dinamikasi, Niderlandiyadagi yuqori texnologiyali laboratoriyalardan mahsulot yetkazib berish barqarorligini hisobga olgan holda, investorlarning noyob rekombinant oqsil ishlab chiqarish majmuasiga egalik qilish uchun to'lashga tayyor bo'lgan premiumini baholash imkonini beradi.
Muhim raqobatchilar
Bozor kapitallashuvi ARGX (argenx)|Bozor qiymati BNTX|Abivax S.A. - Bozor kapitallashuvi|ADMA - Bozor kapitallashuvi|Protagonist Therapeutics (PTGX) - Bozor qiymati|immunovant.com - Bozor qiymati|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor qiymati|Bozor kapitallashuvi ZBIO (Zenas Biopharma, Inc.)|Bozor kapitallashuvi Immunome Bio (IMNM)|GOSS - Bozor qiymati|kalvista.com (KALV) - Bozor bahosi|Septerna (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharma|Bozor bahosi SVRA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|JBIO - Bozor qiymati|Bozor bahosi ACRS|KYTX: Bozor kapitallashuvi|tizianalifesciences.com - Bozor qiymati|CABA (Cabaletta Bio) - Bozor kapitallashuvi|Bozor kapitallashuvi Ventyx Biosciences Inc.|Bozor qiymati Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Bozor qiymati|Bozor qiymati Eledon Pharmaceuticals ELDN|AGEN - Bozor bahosi|Climb Bio - Bozor kapitallashuvi|Bozor kapitallashuvi zurabio.com ZURA|aTyr (ATYR) - Bozor qiymati|Bozor kapitallashuvi ADAG|IMA (ImageneBio) - Bozor kapitallashuvi|STTK - Bozor kapitallashuvi|Bozor bahosi EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Bozor qiymati|Bozor kapitallashuvi IMUX (Immunic)|Bozor kapitallashuvi Atara Biotherapeutics, Inc.|IFRX - Bozor qiymati|Bozor qiymati XFOR (x4pharma.com)|adicetbio.com (ACET) - Bozor qiymati|Bozor qiymati Celularity (CELU)|Bozor bahosi INMB|Bozor kapitallashuvi Barinthus Biotherapeutics Corp|Bozor qiymati Kezar Life Sciences (KZR)|SABS: Bozor bahosi|Akari Therapeutics Plc - Bozor bahosi|Bozor qiymati ENLV|QTTB - Bozor qiymati|GOVX (GeoVax Corp) - Bozor kapitallashuvi|EDSA (Edesa Biotech, Inc.) - Bozor bahosi|IBIO - Bozor kapitallashuvi|Bozor bahosi CARM|Bozor qiymati XTLB|Bozor bahosi BOLT (Bolt Biotherapeutics)|Bozor kapitallashuvi hcwbiologics.com|Bozor qiymati Aptevo Therapeutics Inc. APVO|AIM (aimimmuno.com) - Bozor bahosi|Aditxt Corp - Bozor kapitallashuvi|Bozor qiymati GRI (GRI Bio Inc)|XRTX: Bozor kapitallashuvi|Vyome Therapeutics (HIND) - Bozor kapitallashuvi|Bozor qiymati Revelation Biosciences|INDP: Bozor qiymati|Bozor qiymati Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Bozor bahosi|Bozor kapitallashuvi AFMD (Affimed N.V.)|Bozor qiymati ALLK|HOOKIPA - Bozor kapitallashuvi|IGMS - Bozor kapitallashuvi|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Ocean Biomedical Inc - Bozor qiymati|Bozor qiymati TC BioPharm (Holdings) PLC|Bozor bahosi Third Harmonic Bio Inc (THRD)
